HDAC2 and acute kidney injury: The results of quantitative PCR (qPCR)-based analysis showed that QYG treatment markedly suppressed cisplatin-induced increase of gene expression of HDAC1, HDAC2, HDAC5, HDAC6, and HDAC9 in kidney undergoing AKI (Fig. 2e).